Journal article
Complementary and alternative medicine use in glioma patients in France.
- Le Rhun E Univ. Lille, U1192 - PRISM, 59000, Lille, France. emilie.lerhun@chru-lille.fr.
- Devos P Univ. Lille, CHU Lille, EA 2694 - Santé Publique: Épidémiologie et Qualité des Soins, 59000, Lille, France.
- Bourg V Department of Neurology, Pasteur2 Hospital, Nice Côte D'Azur University, Nice, France.
- Darlix A Department of Medical Oncology, Institut du Cancer de Montpellier, University of Montpellier, Montpellier, France.
- Lorgis V Georges François Leclerc, Anticancer Center, Dijon, France.
- Ahle G Department of Neurology, Hôpitaux Civils, Colmar, France.
- Boone M Department of Medical Oncology, CHU, Amiens, France.
- Taillandier L University Hospital, Nancy, France.
- Curtit E University Hospital, Besançon, France.
- Gras L Centre Léonard de Vinci, Dechy, France.
- Lebrun Frenay C Department of Neurology, Pasteur2 Hospital, Nice Côte D'Azur University, Nice, France.
- Gramatzki D Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.
- Ramirez C CHU Lille, Neuro-oncology, General and Stereotaxic Neurosurgery Department, 59000, Lille, France.
- Simon N Univ. Lille, CHU Lille, EA 7365 - GRITA - Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France.
- Weller M Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.
- 2019-10-23
Published in:
- Journal of neuro-oncology. - 2019
Acupuncture
Brain
Diet
Magnetism
Supplements
Vitamins
Adult
Brain Neoplasms
Complementary Therapies
Female
France
Glioma
Humans
Male
Middle Aged
Surveys and Questionnaires
English
PURPOSE
Complementary and alternative medicine (CAM) use increases in cancer patients, including adult patients with diffuse gliomas.
METHODS
Questionnaires addressing CAM use were distributed to adult patients with gliomas of WHO grades II-IV and ECOG performance score of 0-2 during hospital visits and filled in anonymously. The study was conducted in nine centers in France from May 2017 to May 2018. Descriptive cohort analyses and comparative analyses according to gender, age, WHO grade, and recurrent versus newly diagnosed disease were conducted.
RESULTS
Two hundred twenty-seven questionnaires were collected; 135 patients (59%) were male. Median age was 48 years, 105 patients (46%) declared having glioblastoma, 99 patients (43%) declared having recurrent disease. Hundred-three patients (45%) had modified their alimentary habits after the glioma diagnosis. At the time of the questionnaire, 100 patients (44%) were on complementary treatment, mainly vitamins and food supplements, and 73 patients (32%) used alternative medicine approaches, mainly magnetism and acupuncture. In total, 154 patients (68%) declared using at least one of these approaches. Expenditures exceeding 100 € per month were reported by users in 14% for modification of alimentary habits, in 25% for complementary treatment, and in 18% for alternative medicines. All approaches were commonly considered as improving quality of life and experienced as efficient, notably those associated with more expenditures.
CONCLUSIONS
CAM are frequently used by glioma patients in France. Underlying needs and expectations, as well as potential interactions with tumor-specific treatments, and financial and quality of life burden, should be discussed with patients and caregivers.
Complementary and alternative medicine (CAM) use increases in cancer patients, including adult patients with diffuse gliomas.
METHODS
Questionnaires addressing CAM use were distributed to adult patients with gliomas of WHO grades II-IV and ECOG performance score of 0-2 during hospital visits and filled in anonymously. The study was conducted in nine centers in France from May 2017 to May 2018. Descriptive cohort analyses and comparative analyses according to gender, age, WHO grade, and recurrent versus newly diagnosed disease were conducted.
RESULTS
Two hundred twenty-seven questionnaires were collected; 135 patients (59%) were male. Median age was 48 years, 105 patients (46%) declared having glioblastoma, 99 patients (43%) declared having recurrent disease. Hundred-three patients (45%) had modified their alimentary habits after the glioma diagnosis. At the time of the questionnaire, 100 patients (44%) were on complementary treatment, mainly vitamins and food supplements, and 73 patients (32%) used alternative medicine approaches, mainly magnetism and acupuncture. In total, 154 patients (68%) declared using at least one of these approaches. Expenditures exceeding 100 € per month were reported by users in 14% for modification of alimentary habits, in 25% for complementary treatment, and in 18% for alternative medicines. All approaches were commonly considered as improving quality of life and experienced as efficient, notably those associated with more expenditures.
CONCLUSIONS
CAM are frequently used by glioma patients in France. Underlying needs and expectations, as well as potential interactions with tumor-specific treatments, and financial and quality of life burden, should be discussed with patients and caregivers.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1007/s11060-019-03315-8
- PMID 31637628
- Persistent URL
- https://sonar.ch/global/documents/47686
Statistics
Document views: 28
File downloads: